Bradley Canino

Stock Analyst at Stifel

(0.55)
# 2634
Out of 5,441 analysts
103
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
BDTX Black Diamond Therap...
Maintains: Buy
16 15
2.29 555.02% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
0.62 141.94% 8 Mar 7, 2025
CGEM Cullinan Therapeutic...
Maintains: Buy
23 19
7.09 167.98% 2 Feb 28, 2025
RLAY Relay Therapeutics
Maintains: Buy
27 23
3.24 609.88% 5 Feb 27, 2025
ARVN Arvinas
Maintains: Buy
63 51
6.58 675.08% 6 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 115
22.68 407.05% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
n/a n/a 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 41
12.5 228% 5 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
5.54 242.96% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
46.7 -10.06% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
28.23 41.69% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
74.98 80.05% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
9.19 117.63% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.05 852.38% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.4 614.29% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
64.6 53.25% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
2.42 478.51% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
129.46 0.42% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
37.69 45.93% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
25.59 -10.12% 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
4.07 489.68% 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022